|Title:||Guidelines for HIV diagnosis and monitoring of antiretroviral therapy, Rev.2|
|Authors:||World Health Organization, Regional Office for South-East Asia|
|Publisher:||WHO Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||Laboratory support is critical in all the areas of HIV diagnosis and management. Diagnosis of HIV infection cannot be established by any means other than blood tests by the laboratory. CD4 lymphocyte count is a prerequisite for the initiation of antiretroviral therapy and for monitoring treatment outcome. Both immunological and microbiological monitoring of antiretroviral therapy is therefore exclusively dependent on an efficient laboratory service. While laboratory support to HIV/AIDS programmes is very important, the infrastructure, expertise and networking require strengthening in most countries of our Region. These Guidelines aim to assist Member Countries in scaling up ART and responding to the rapidly evolving HIV/AIDS epidemic.|
|Gov't Doc #:||SEA-HLM-382 (Rev.2)|
|Appears in Collections:||SEARO Publications|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.